PharmaShots | Incisive News in 3 Shots

Subscribe Now

Age

AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

September 1, 2020

Tolmar's Fensolvi Received the US FDA's Approval to Treat Pediatric Patients Two Years of Age and Older withntral Prec Ceocious Puberty (CPP)

Tolmar's Fensolvi Received the US FDA's Approval to Treat Pediatric Patients Two Years of Age and Older withntral Prec Ceocious Pu...

May 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us